Oklahoma Senate Bill SB1186

Oklahoma 2026 Regular Session

• Introduced: 4/7/25
• Refer: 2/3/26

Caption

Practice of pharmacy; designating certain drug as over-the-counter. Effective date.

Summary

SB 1186 would amend Oklahoma pharmacy law to define “over-the-counter medication” and specifically classify ivermectin suitable for human use as an over-the-counter drug. The bill states that ivermectin could be sold or purchased in the state without a prescription and without consultation with a health care professional, notwithstanding any conflicting law. The measure creates a new section of Title 59 of the Oklahoma Statutes and is set to take effect on November 1, 2026. In practical terms, it would remove prescription and pharmacist-consultation barriers for human-use ivermectin and make the drug available through ordinary retail channels as an OTC medication under state law.

Impact

SB 1186 would change Oklahoma’s pharmacy and controlled-dispensing rules by expressly authorizing over-the-counter sale of human-use ivermectin. It would affect pharmacists, retailers, prescribers, and consumers by eliminating the need for a prescription or health care professional consultation for this drug, and it would override any contrary state law provisions once effective.

Sentiment

The available record shows little formal debate or recorded voting on the bill, so there is no clear committee or floor sentiment documented in the materials provided. The bill’s introduction and referral suggest it was treated as a pharmacy-policy measure, but the absence of transcripts or votes means support and opposition cannot be measured from the record here.

Contention

The main point of contention is likely to be whether ivermectin should be made available without medical oversight. Supporters would likely view the bill as expanding consumer access and personal choice, while opponents would likely raise concerns about safety, appropriate use, and bypassing physician or pharmacist consultation. Because no committee transcript or vote record is included, the specific arguments and the legislators or stakeholders advancing them are not documented in the provided materials.